202 related articles for article (PubMed ID: 36290282)
1. Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma.
Chen C; Lan MS
Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290282
[TBL] [Abstract][Full Text] [Related]
2. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma.
Chen C; Wu J; Hicks C; Lan MS
Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
[TBL] [Abstract][Full Text] [Related]
3. A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma.
Chen C; Lan MS
Cell Signal; 2020 Dec; 76():109785. PubMed ID: 32966884
[TBL] [Abstract][Full Text] [Related]
4. 5'-Iodotubercidin represses
Chen C; Breslin MB; Guidry JJ; Lan MS
J Biol Chem; 2019 Apr; 294(14):5456-5465. PubMed ID: 30755485
[TBL] [Abstract][Full Text] [Related]
5. Small Molecules Targeting INSM1 for the Treatment of High-Risk Neuroblastoma.
Lan MS; Chen C
Biology (Basel); 2023 Aug; 12(8):. PubMed ID: 37627018
[TBL] [Abstract][Full Text] [Related]
6. Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.
Chen C; Breslin MB; Lan MS
Cell Signal; 2018 Jun; 46():83-91. PubMed ID: 29501727
[TBL] [Abstract][Full Text] [Related]
7. INSM1 increases N-myc stability and oncogenesis via a positive-feedback loop in neuroblastoma.
Chen C; Breslin MB; Lan MS
Oncotarget; 2015 Nov; 6(34):36700-12. PubMed ID: 26456864
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
9. Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development.
Yuan Y; Alzrigat M; Rodriguez-Garcia A; Wang X; Bexelius TS; Johnsen JI; Arsenian-Henriksson M; Liaño-Pons J; Bedoya-Reina OC
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760568
[TBL] [Abstract][Full Text] [Related]
10. Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.
Chen C; Notkins AL; Lan MS
Mol Cancer Res; 2019 Aug; 17(8):1597-1604. PubMed ID: 31113827
[TBL] [Abstract][Full Text] [Related]
11. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
12. The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line.
Yi B; Yang J; Wang L
Tumour Biol; 2014 Apr; 35(4):3229-35. PubMed ID: 24293393
[TBL] [Abstract][Full Text] [Related]
13. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
14. Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.
Lee AC; Shih YY; Zhou F; Chao TC; Lee H; Liao YF; Hsu WM; Hong JH
J Mol Med (Berl); 2019 Mar; 97(3):325-339. PubMed ID: 30612140
[TBL] [Abstract][Full Text] [Related]
15. INSM1 promotes breast carcinogenesis by regulating C-MYC.
Guan Y; Sun Y; Liu Z; Zhang Y; Cao M; Wang W; Tao J; Yao Y
Am J Cancer Res; 2023; 13(8):3500-3516. PubMed ID: 37693125
[TBL] [Abstract][Full Text] [Related]
16. N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.
Armstrong MB; Mody RJ; Ellis DC; Hill AB; Erichsen DA; Wechsler DS
Neoplasia; 2013 Dec; 15(12):1363-70. PubMed ID: 24403858
[TBL] [Abstract][Full Text] [Related]
17. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression.
Zhao X; Li D; Pu J; Mei H; Yang D; Xiang X; Qu H; Huang K; Zheng L; Tong Q
Oncogene; 2016 Jul; 35(27):3565-76. PubMed ID: 26549029
[TBL] [Abstract][Full Text] [Related]
18. Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
Montavon G; Jauquier N; Coulon A; Peuchmaur M; Flahaut M; Bourloud KB; Yan P; Delattre O; Sommer L; Joseph JM; Janoueix-Lerosey I; Gross N; Mühlethaler-Mottet A
Oncotarget; 2014 Jun; 5(12):4452-66. PubMed ID: 24947326
[TBL] [Abstract][Full Text] [Related]
19. N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.
Kang J; Rychahou PG; Ishola TA; Mourot JM; Evers BM; Chung DH
Oncogene; 2008 Jun; 27(28):3999-4007. PubMed ID: 18278068
[TBL] [Abstract][Full Text] [Related]
20. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]